LEVETIRACETAM RETARD · NXPLEVE/24/P3-6
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy
Sponsor: NEURAXPHARM
Phase: III
Area: Epilepsy